Scott Gottlieb, MD
Former FDA CommissionerPhysician and resident fellow at the American Enterprise Institute.
Authored Items
April 9, 2020 | Web Exclusives
Mr Slotnik opened the session with an inside look at Washington, addressing some of the changes to oncology care policies and operations from the COVID-19 pandemic. He outlined a quick overview of the initiatives from the Centers for Medicare & Medicaid Services (CMS), including new guidelines and the easing of some restrictions on physicians’ options for telemedicine.
Last modified: March 10, 2021